126 related articles for article (PubMed ID: 15160964)
1. Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.
Candoni A; Tiribelli M; Fanin R
Leuk Lymphoma; 2004 Apr; 45(4):821-4. PubMed ID: 15160964
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial.
Finazzi G; Ruggeri M; Rodeghiero F; Barbui T
Br J Haematol; 2000 Sep; 110(3):577-83. PubMed ID: 10997967
[TBL] [Abstract][Full Text] [Related]
3. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
[No Abstract] [Full Text] [Related]
4. Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.
Radaelli F; Onida F; Rossi FG; Zilioli VR; Colombi M; Usardi P; Calori R; Zanella A
Hematology; 2008 Aug; 13(4):195-202. PubMed ID: 18796244
[TBL] [Abstract][Full Text] [Related]
5. Multiple granulocytic sarcomas in essential thrombocythemia.
Tanaka Y; Nagai Y; Mori M; Fujita H; Togami K; Kurata M; Matsushita A; Maeda A; Nagai K; Tanaka K; Takahashi T
Int J Hematol; 2006 Dec; 84(5):413-6. PubMed ID: 17189221
[TBL] [Abstract][Full Text] [Related]
6. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
Randi ML; Fabris F; Girolami A
Haematologica; 1999 Nov; 84(11):1049-50. PubMed ID: 10553169
[No Abstract] [Full Text] [Related]
7. Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia.
Randi ML; Fabris F; Girolami A
Leuk Lymphoma; 2000 Apr; 37(3-4):379-85. PubMed ID: 10752989
[TBL] [Abstract][Full Text] [Related]
8. Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
Wong GC; Lee LH
Am J Hematol; 2006 Aug; 81(8):624-6. PubMed ID: 16823822
[TBL] [Abstract][Full Text] [Related]
9. Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.
Azagury M; Martelli JM; Morcelet M; Duboucher C; Flandrin G
Leuk Lymphoma; 2003 Jun; 44(6):1067-9. PubMed ID: 12854912
[TBL] [Abstract][Full Text] [Related]
10. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Alvarez-Larrán A; Martínez-Avilés L; Hernández-Boluda JC; Ferrer-Marín F; Antelo ML; Burgaleta C; Mata MI; Xicoy B; Martínez-Trillos A; Gómez-Casares MT; Durán MA; Marcote B; Ancochea A; Senín A; Angona A; Gómez M; Vicente V; Cervantes F; Bellosillo B; Besses C
Ann Hematol; 2014 Dec; 93(12):2037-43. PubMed ID: 24981691
[TBL] [Abstract][Full Text] [Related]
11. Second malignancies in patients with essential thrombocythaemia.
Randi ML; Fabris F; Girolami A
Br J Haematol; 2002 Mar; 116(4):923-4. PubMed ID: 11886403
[No Abstract] [Full Text] [Related]
12. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
Furgerson JL; Vukelja SJ; Baker WJ; O'Rourke TJ
Am J Hematol; 1996 Feb; 51(2):137-40. PubMed ID: 8579054
[TBL] [Abstract][Full Text] [Related]
14. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
Iványi JL; Marton É; Plander M; Szendrei T
Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
Quintás-Cardama A; Pérez-Encinas M; Gonzalez S; Bendaña A; Bello JL
Ann Hematol; 1999 Apr; 78(4):187-8. PubMed ID: 10348150
[TBL] [Abstract][Full Text] [Related]
16. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of hydroxyurea in patients with essential thrombocythemia.
Finazzi G; Barbui T
Pathol Biol (Paris); 2001 Mar; 49(2):167-9. PubMed ID: 11317964
[TBL] [Abstract][Full Text] [Related]
18. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Nielsen I; Hasselbalch HC
Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
[TBL] [Abstract][Full Text] [Related]
19. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.
Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Brusamolino E; Passamonti F; Volpe G; Pistorio A; Giardini I; Rocca B; Caresana M; Lazzarino M; Bernasconi C
Leukemia; 2002 Oct; 16(10):2078-83. PubMed ID: 12357360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
